Search results
Results From The WOW.Com Content Network
To begin the certification process applicants must be a physician medical director at a long-term care facility, and have completed a post-graduate training program accredited by the U.S. Accreditation Council for Graduate Medical Education or American Osteopathic Association, or a Canadian Royal College of Physicians and Surgeons or College of ...
Tapentadol is a novel opioid that displays high affinity and selectivity for the μ-opioid receptor; In a human liability pharmacology study conducted by the sponsor, it was found that tapentadol displays a high abuse potential similar to hydromorphone , a controlled substance with a similar risk of abuse, misuse and diversion; and
The Anti-Drug Abuse Act of 1988, which created the Office of National Drug Control Policy, was the product of bi-partisan support.It was co-sponsored in the House of Representatives by parties' leaders, Tom Foley and Robert Michel, [5] and it passed by margins of 346–11 and 87–3 in the House and Senate, respectively. [6]
Clinical Opiate Withdrawal Scale (COWS) is a method used by registered practitioners to measure the severity of a patient's opioid withdrawal symptoms. This method consists of a series of 11 topics each comprising 4 - 5 common symptoms experienced by a patient undergoing opioid withdrawal.
An equianalgesic chart is a conversion chart that lists equivalent doses of analgesics (drugs used to relieve pain). Equianalgesic charts are used for calculation of an equivalent dose (a dose which would offer an equal amount of analgesia) between different analgesics. [1]
Publicis, a French marketing company, agreed to pay $350 million within the next two months and will not take on any more opioid clients, according to New York Attorney General Letitia James.
The opioid crisis contributed to more than 500,000 deaths in the U.S. in two decades. At the epicenter — three major pharmaceutical distributors and manufacturer Johnson & Johnson.
"Pain ladder", or analgesic ladder, was created by the World Health Organization (WHO) as a guideline for the use of drugs in the management of pain. Originally published in 1986 for the management of cancer pain, it is now widely used by medical professionals for the management of all types of pain.